CTSO יחס שווי שוק לנכסים נקיים CytoSorbents Corporation
Cytosorbents (CTSO) develops high-tech blood purification filters, seeking FDA clearance for the DrugSorb-ATR system and increasing the sale of consumables in Europe. The market share price trend, recorded at -18.88, complements data regarding a loyal development team and the recruitment of sales experts. The business relies on partnerships with intensive care specialists through educational programs and joint research.
CTSO (Cytosorbents): פילוחים אנליטיים ודוחות לפי אינדיקטורים
Cytosorbents is implementing automated digital monitoring into the production of blood purification cartridges. By analyzing the company's relative capitalization ratio, an investor can see the relationship between the business's market value and its actual net assets. This metric separates speculative price volatility from fundamental changes in capital. An increase in this indicator signals that the market is revaluing the company's technological potential. This allows for the determination of the fair value of shares relative to the balance sheet.